Goals, Mission & Vision

The goal of MGNet is to advance therapeutic development. To do so we have four specific aims:

  1. Improve the tools scientists and doctors have for performing clinical trials through rigorous monitoring of patients over time and evaluate better measures of how patients are doing.
  2. Identify objective measures (biomarkers) to show how the disease is responding to treatment and better predict treatment response or side effects, to improve the design of clinical trials and care of patients in clinical practice.
  3. Enhance the education of young investigators focusing their careers on rare diseases and specifically MG.
  4. Improve the awareness of scientists, physicians, and the public regarding the unique needs of patients with MG through training of clinician scientists and engagement of the patient and scientific communities in clinical research and therapeutic development.